Caris welcomes the University of Mississippi Medical Center (UMMC) to its extensive and expanding network of leading cancer institutions committed to improving patient outcomes through innovations in precision medicine. “UMMC’s commitment to cutting-edge therapy, clinical trials and interdisciplinary collaboration makes them a valuable Caris POA member. We’re eager to collaborate with their investigators on our shared mission of improving the outcomes of all patients affected by cancer,” said George Sledge, Jr., MD, EVP and Chief Medical Officer of Caris.” Learn more: https://lnkd.in/gSNarrna
Caris Life Sciences
Biotechnology Research
Irving, Texas 55,923 followers
Fulfilling the promise of precision medicine through quality and innovation.
About us
Caris Life Sciences® (Caris) is the leading next-generation TechBio company and precision medicine pioneer that is actively developing and delivering innovative solutions to revolutionize healthcare and improve the human condition. Through comprehensive molecular profiling (Whole Exome and Whole Transcriptome Sequencing) and the application of advanced artificial intelligence (AI) and machine learning algorithms, Caris has created the large-scale, clinico-genomic database and computing capability needed to analyze and unravel the molecular complexity of disease. This convergence of sequencing power, big data and AI technologies provides an unmatched platform to deliver the next-generation of precision medicine tools for early detection, diagnosis, monitoring, therapy selection and drug development. Headquartered in Irving, Texas, Caris has offices in Phoenix, New York, Tokyo, Japan and Basel, Switzerland. Caris or its distributor partners provide services in the U.S., Europe, Asia and other international markets.
- Website
-
https://www.carislifesciences.com
External link for Caris Life Sciences
- Industry
- Biotechnology Research
- Company size
- 1,001-5,000 employees
- Headquarters
- Irving, Texas
- Type
- Privately Held
- Founded
- 1996
- Specialties
- Biotechnology, Molecular Profiling, Genomics, Personalized Medicine, Diagnostics, Theranostics, Panomics, Precision Medicine, and Comprehensive Genomic Profiling
Locations
-
Primary
750 W John Carpenter Fwy
Irving, Texas 75039, US
-
4610 S 44th Pl
Phoenix, Arizona 85040, US
-
St. Jakobsstrasse
199, 4052 Basel, CH
Employees at Caris Life Sciences
Updates
-
Our best measure of success is the ability to help extend and improve the lives of cancer patients. Learn about the benefits of #molecularprofiling through our patient stories. https://lnkd.in/dFFX4-3t #precisionmedicine
-
Caris molecular testing can identify genetic errors, whether they are found in a patient's DNA, RNA, or proteins, to help oncologists recommend the best therapy options. Learn more: https://ow.ly/2Nl150SG3M9 #precisionmedicine #molecularprofiling #AI
-
Caris Assure is an advanced assay that analyzes over 23,000 genes at the DNA and RNA level, using whole exome and whole transcriptome sequencing. This approach offers exceptional accuracy and precision in evaluating crucial molecular features of a patient's cancer. Find out how Caris has transformed liquid biopsy profiling: https://lnkd.in/gZm92Zdg. #precisionmedicine #molecularprofiling
-
-
Caris is dedicated to helping improve the lives of as many people as possible. Our advanced profiling approach analyzes DNA, RNA, and proteins to better understand cancer at the molecular level. Learn more: http://ow.ly/8KFC50MgNNr
-
Check out the inside of our 66,000 sq. ft. tissue lab for an exclusive look at our cutting-edge molecular profiling facility. Discover how Caris's comprehensive molecular profiling can guide more personalized treatment decisions and improve patient outcomes: https://ow.ly/5l3Y50Sx5Fj
-
Unleash the potential of liquid biopsy with Caris Assure, an innovative multi-cancer assay that provides deep molecular insights from a simple blood sample. Explore how this powerful liquid biopsy assay can revolutionize patient care. Start ordering: https://lnkd.in/gZm92Zdg #molecularprofiling #precisionmedicine #liquidprofiling
-
-
Caris Life Sciences is committed to bringing awareness to sarcoma cancers. During Sarcoma Awareness Month, we are focused on educating individuals about the importance of molecular profiling in changing the course of treatment. Learn more about how Caris testing can make a difference: https://ow.ly/4jYE50StOrx #SarcomaAwarenessMonth
-
Following a great ASCO 2024, we spotlight Dr. George Sledge, Jr., former President of ASCO and current Caris Chief Medical Officer. In this feature, he shares his conference insights, his journey as an oncologist and how his passion for precision medicine led him to Caris. Learn More: https://lnkd.in/gGrtUEEB
-
-
Caris expands its extensive network of leading cancer institutions committed to improving patient outcomes through innovations in precision medicine by welcoming Mass General Cancer Center. “We are thrilled to welcome Mass General Cancer Center, one of the world’s most respected centers, to the Caris Precision Oncology Alliance,” said George Sledge, Jr., MD, EVP and Chief Medical Officer of Caris. “We’re eager to work with their researchers and investigators on our shared mission of improving outcomes of all patients affected by cancer through precision oncology research.” Learn more: https://lnkd.in/ggni-zgg
-